Tetrahydroxystilbene glucoside improves learning and (or) memory ability of aged rats and may be connected to the APP pathway

Canadian Journal of Physiology and Pharmacology

Volumn 89, Issue 11, 2011, Pages 801-809

  Hou, Ying ^a   Yang, Qidong ^a   Zhou, Lin ^a   Du, Xiaoping ^a   Li, Min ^a   Yuan, Mei ^a   Zhou, Zhiwen ^a   Li, Zhenguo ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

A disintegrin and metalloproteinase 10 (adam10); Aging; APP cleaving enzyme (appce); Beta site APP cleaving enzyme 1 (bace1); Tetrahydroxystilbene glucoside (tsg)

Indexed keywords

2,3,5,4' TETRAHYDROXYSTILBENE 2 O BETA DEXTRO GLUCOSIDE; ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; GLUCOSIDE; MATRIX METALLOPROTEINASE 17; UNCLASSIFIED DRUG;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; GENE TARGETING; HIPPOCAMPUS; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION PROFILING; GLUCOSIDES; HIPPOCAMPUS; LEARNING; MALE; MAZE LEARNING; MEMORY; NOOTROPIC AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SOFTWARE; STILBENES; TIME FACTORS;

EID: 80055071473     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y11-081     Document Type: Article

References (60)

1. Arslanova, D., Yang, T., Xu, X., Wong, S.T., Augelli-Szafran, C.E., and Xia, W. 2010. Phenotypic analysis of images of zebrafish treated with Alzheimer's gamma-secretase inhibitors. BMC Biotechnol. 10(1): 24. doi:10.1186/1472-6750-10-24.
2. Balducci, C., Mehdawy, B., Mare, L., Giuliani, A., Lorenzini, L., Sivilia, S., et al. 2011. The γ-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaquefree Tg2576 mice. J. Alzheimers Dis. 24(4): 799-816.
3. Berezovska, O., Xia, M.Q., Page, K., Wasco, W., Tanzi, R.E., and Hyman, B.T. 1997. Developmental regulation of presenilin mRNA expression parallels notch expression. J. Neuropathol. Exp. Neurol. 56(1): 40-44. doi:10.1097/00005072-199701000-00004.
4. Bernstein, H.G., Bukowska, A., Krell, D., Bogerts, B., Ansorge, S., and Lendeckel, U. 2003. Comparative localization of ADAMs 10 and 15 in human cerebral cortex normal aging, Alzheimer disease and Down syndrome. J. Neurocytol. 32(2): 153-160. doi:10.1023/B:NEUR.0000005600.61844.a6.
5. Buxbaum, J.D., Liu, K.N., Luo, Y., Slack, J.L., Stocking, K.L., Peschon, J.J., et al. 1998. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273(43): 27765-27767. doi:10.1074/jbc.273.43.27765.
6. Cacabelos, R., Fernandez-Novoa, L., Lombardi, V., Kubota, Y., and Takeda, M. 2005. Molecular genetics of Alzheimer's disease and aging. Methods Find. Exp. Clin. Pharmacol. 27(Suppl. A): 1-573.
7. Chow, V.W., Savonenko, A.V., Melnikova, T., Kim, H., Price, D.L., Li, T., and Wong, P.C. 2010. Modeling an anti-amyloid combination therapy for Alzheimer's disease. Sci. Transl. Med. 2 (13): 13ra1. doi:10.1126/scitranslmed.3000337.
8. Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., et al. 1997. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3(1): 67-72. doi:10.1038/nm0197-67.
9. Dayan, A.D. 1970. Quantitative histological studies on the aged human brain. I. Senile plaques and neurofibrillary tangles in "normal" patients. Acta Neuropathol. 16(2): 85-94. doi:10.1007/BF00687663.
10. Dickson, D.W., Crystal, H.A., Bevona, C., Honer, W., Vincent, I., and Davies, P. 1995. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol. Aging, 16(3): 285-298, discussion 298-304. doi:10.1016/0197-4580(95)00013-5.
11. Dong, H., Martin, M.V., Chambers, S., and Csernansky, J.G. 2007. Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice. J. Comp. Neurol. 500(2): 311-321. doi:10.1002/cne.21176.
12. Evin, G., Barakat, A., and Masters, C.L. 2010. BACE: Therapeutic target and potential biomarker for Alzheimer's disease. Int. J. Biochem. Cell Biol. 42(12): 1923-1926. doi:10.1016/j.biocel.2010.08.017.
13. Fukumoto, H., Rosene, D.L., Moss, M.B., Raju, S., Hyman, B.T., and Irizarry, M.C. 2004. Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am. J. Pathol. 164(2): 719-725. doi:10.1016/S0002-9440(10)63159-8.
14. Furukawa, K., Sopher, B.L., Rydel, R., Begley, J.G., Pham, D.G., Martin, G.M., et al. 1996. Increased activity- regulating and neuroprotective efficacy of a secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparinbinding domain. J. Neurochem. 67(5): 1882-1896. doi:10.1046/j.1471-4159.1996.67051882.x
15. Fuso, A., Nicolia, V., Cavallaro, R.A., Ricceri, L., D'Anselmi, F., Coluccia, P., et al. 2008. B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol. Cell. Neurosci. 37(4): 731-746. doi:10.1016/j.mcn.2007.12.018.
16. Goddard, D.R., Bunning, R.A., and Woodroofe, M.N. 2001. Astrocyte and endothelial cell expression of ADAM 17 (TACE) in adult human CNS. Glia, 34(4): 267-271. doi:10.1002/glia.1060.
17. Golde, T.E. 2005. The Abeta hypothesis: leading us to rationallydesigned therapeutic strategies for the treatment or prevention of Alzheimer disease. Brain Pathol. 15(1): 84-87. doi:10.1111/j.1750-3639.2005.tb00104.x.
18. Hata, S., Fujishige, S., Araki, Y., Kato, N., Araseki, M., Nishimura, M., et al. 2009. Alcadein cleavages by amyloid beta-precursor protein (APP) α- and γ-secretases generate small peptides, p3-Alcs, indicating Alzheimer disease-related γ-secretase dysfunction. J. Biol. Chem. 284(52): 36024-36033. doi:10.1074/jbc.M109.057497.
19. Head, E., Callahan, H., Muggenburg, B.A., Cotman, C.W., and Milgram, N.W. 1998. Visual-discrimination learning ability and beta-amyloid accumulation in the dog. Neurobiol. Aging, 19(5): 415-425. doi:10.1016/S0197-4580(98)00084-0.
20. Higuchi, M., Iwata, N., and Saido, T.C. 2005. Understanding molecular mechanisms ofproteolysis in Alzheimer's disease: progress toward therapeutic interventions. Biochim. Biophys. Acta, 1751(1): 60-67.
21. Hof, P.R. 1997. Morphology and neurochemical characteristics of the vulnerable neurons in brain aging and Alzheimer's disease. Eur. Neurol. 37(2): 71-81. doi:10.1159/000117414.
22. Jin, S., Agerman, K., Kolmodin, K., Gustafsson, E., Dahlqvist, C., Jureus, A., et al. 2010. Evidence for dimeric BACE-mediated APP processing. Biochem. Biophys. Res. Commun. 393(1): 21-27. doi:10.1016/j.bbrc.2010.01.064.
23. Kärkkäinen, I., Rybnikova, E., Pelto-Huikko, M., and Huovila, A.P. 2000. Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol. Cell. Neurosci. 15 (6): 547-560. doi:10.1006/mcne.2000.0848.
24. Kikuchi, M., Hirosawa, T., Yokokura, M., Yagi, S., Mori, N., Yoshikawa, E., et al. 2011. Effects of brain amyloid deposition and reduced glucose metabolism on the default mode of brain function in normal aging. J. Neurosci. 31(31): 11193-11199. doi:10.1523/JNEUROSCI.2535-11.2011.
25. Kojro, E., and Fahrenholz, F. 2005. The non-amyloidogenic pathway: structure and function of alpha-secretases. Subcell. Biochem. 38: 105-127. doi:10.1007/0-387-23226-5_5.
26. Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., et al. 1999. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. U.S.A. 96(7): 3922-3927. doi:10.1073/pnas.96.7.3922.
27. Lammich, S., Buell, D., Zilow, S., Ludwig, A.K., Nuscher, B., Lichtenthaler, S.F., et al. 2010. Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5́-untranslated region. J. Biol. Chem. 285(21): 15753-15760. doi:10.1074/jbc.M110.110742.
28. Liu, C., Zhang, Q., and Zhou, Q. 1991. Assay of stilbene glucoside in Polygonum multiflorum Thunb. and its processed products. [In Chinese]. Zhongguo Zhong Yao Za Zhi, 16(8): 469-472, 511.
29. Luo, H.B., Yang, J.S., Shi, X.Q., Fu, X.F., and Yang, Q.D. 2009. Tetrahydroxy stilbene glucoside reduces the cognitive impairment and overexpression of amyloid precursor protein induced by aluminum exposure. Neurosci. Bull. 25(6): 391-396. doi:10.1007/s12264-009-0601-4.
30. Marcinkiewicz, M., and Seidah, N.G. 2000. Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM-10 in mouse and human brain. J. Neurochem. 75(5): 2133-2143. doi:10.1046/j.1471-4159.2000.0752133.x.
31. Marks, N., and Berg, M.J. 2003. APP processing enzymes (secretases) as therapeutic targets: insights from the use of transgenics (Tgs) and transfected cells. Neurochem. Res. 28(7): 1049-1062. doi:10.1023/A:1023211323853.
32. Maskos, K., Fernandez-Catalan, C., Huber, R., Bourenkov, G.P., Bartunik, H., Ellestad, G.A., et al. 1998. Crystal structure of the catalytic domain of human tumor necrosis factor-alpha converting enzyme. Proc. Natl. Acad. Sci. U.S.A. 95(7): 3408-3412. doi:10.1073/pnas.95.7.3408.
33. Meyer-Luehmann, M., Mielke, M., Spires-Jones, T.L., Stoothoff, W., Jones, P., Bacskai, B.J., and Hyman, B.T. 2009. A reporter of local dendritic translocation shows plaque-related loss of neural system function in APP-transgenic mice. J. Neurosci. 29(40): 12636-12640. doi:10.1523/JNEUROSCI.1948-09.2009.
34. Meziane, H., Dodart, J.-C., Mathis, C., Little, S., Clemens, J., Paul, S. M., et al. 1998. Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc. Natl. Acad. Sci. U.S.A. 95(21): 12683-12688. doi:10.1073/pnas.95.21.12683.
35. Morris, R. 1984. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods, 11(1): 47-60. doi:10.1016/0165-0270(84)90007-4.
36. Nistor, M., Don, M., Parekh, M., Sarsoza, F., Goodus, M., Lopez, G. E., et al. 2007. Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain. Neurobiol. Aging, 28(10): 1493-1506. doi:10.1016/j.neurobiolaging.2006.06.023.
37. Nunan, J., and Small, D.H. 2000. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett. 483(1): 6-10. doi:10.1016/S0014-5793(00)02076-7.
38. Panegyres, P.K., and Toufexis, K. 2005. Presenilin immunoreactivity in Alzheimer's disease. Eur. J. Neurol. 12(9): 700-706. doi:10.1111/j.1468-1331.2005.01050.x.
39. Pop, V., Head, E., Berchtold, N.C., Glabe, C.G., Studzinski, C.M., Weidner, A.M., et al. 2010. Abeta aggregation profiles and shifts in APP processing favor amyloidogenesis in canines. Neurobiol. Aging, In press. doi:10.1016/j.neurobiolaging.2010.02.008.
40. Postina, R. 2008. A closer look at α-secretase. Curr. Alzheimer Res. 5 (2): 179-186. doi:10.2174/156720508783954668.
41. Qiu, H., Jin, G., Jin, R., and Zhao, W. 2007. Analysis of variance of repeated data measured by water maze with SPSS. [In Chinese]. Zhong Xi Yi Jie He Xue Bao, 5(1): 101-105. doi:10.3736/jcim20070121.
42. Rowe, J.W., and Kahn, R.L. 1987. Human aging: usual and successful. Science, 237(4811): 143-149. doi:10.1126/science.3299702.
43. Ryu, G., Ju, J.H., Park, Y.J., Ryu, S.Y., Choi, B.W., and Lee, B.H. 2002. The radical scavenging effects of stilbene glucosides from Polygonum multiflorum. Arch. Pharm. Res. 25(5): 636-639. doi:10.1007/BF02976935.
44. Selkoe, D.J. 1996. Amyloid b-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271(31): 18295-18298.
45. Shankar, G.M., Bloodgood, B.L., Townsend, M., Walsh, D.M., Selkoe, D.J., and Sabatini, B.L. 2007. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci. 27(11): 2866-2875. doi:10.1523/JNEUROSCI.4970-06.2007.
46. Sisodia, S.S., and St George-Hyslop, P.H. 2002. Gamma-secretase, notch, abeta and Alzheimer's disease: where do the presenilins fit in? Nat. Rev. Neurosci. 3(4): 281-290. doi:10.1038/nrn785.
47. Studzinski, C.M., Araujo, J.A., and Milgram, N.W. 2005. The canine model of human cognitive aging and dementia: pharmacological validity of the model for assessment of human cognitiveenhancing drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry, 29(3): 489-498. doi:10.1016/j.pnpbp.2004.12.014.
48. Studzinski, C.M., Christie, L.A., Araujo, J.A., Burnham, W.M., Head, E., Cotman, C.W., and Milgram, N.W. 2006. Visuospatial function in the beagle dog: an early marker of cognitive decline in a model of human aging and dementia. Neurobiol. Learn. Mem. 86 (2): 197-204. doi:10.1016/j.nlm.2006.02.005.
49. Tomita, S., Kirino, Y., and Suzuki, T. 1998. A basic amino acid in the cytoplasmic domain of Alzheimer's beta-amyloid precursor protein (APP) is essential for cleavage of APP at the alpha-site. J. Biol. Chem. 273(30): 19304-19310. doi:10.1074/jbc.273.30.19304.
50. Tomlinson, B.E., Blessed, G., and Roth, M. 1968. Observations on the brains of non-demented old people. J. Neurol. Sci. 7(2): 331-356. doi:10.1016/0022-510X(68)90154-8.
51. Vassar, R., Bennett, B.D., Babu-Khan, S., Kahn, S., Mendiaz, E.A., Denis, P., et al. 1999. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science, 286(5440): 735-741. doi:10.1126/science.286.5440.735.
52. Wang, W., Wang, R., Ai, H.X., Xu, J.D., and Li, L. 2006. Distribution and metabolism of tetrahydroxystilbene glucoside from Polygonum multiflorum in rabbits. Chin. Med. Res. Pract., 2: 108-110.
53. Wang, R., Tang, Y., Feng, B., Ye, C., Fang, L., Zhang, L., and Li, L. 2007. Changes in hippocampal synapses and learning-memory abilities in age-increasing rats and effects of Tetrahydroxystilbene glucoside in aged rats. Neuroscience, 149(4): 739-746. doi:10.1016/j.neuroscience.2007.07.065.
54. Wang, T., Yang, Y.J., Wu, P.F., Wang, W., Hu, Z.L., Long, L.H., et al. 2011. Tetrahydroxystilbene glucoside, a plant-derived cognitive enhancer, promotes hippocampal synaptic plasticity. Eur. J. Pharmacol. 650(1): 206-214. doi:10.1016/j.ejphar.2010.10.002.
55. Wei, W., Nguyen, L.N., Kessels, H.W., Hagiwara, H., Sisodia, S., and Malinow, R. 2010. Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat. Neurosci. 13(2): 190-196. doi:10.1038/nn.2476.
56. Yoon, S.Y., Choi, J.E., Yoon, J.H., Huh, J.W., and Kim, D.H. 2006. BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Neurobiol. Dis. 22(2): 435-444. doi:10.1016/j.nbd.2005.12.013.
57. Zhang, L., Li, L., and Li, Y.L. 2004. Mechanism of the protection of tetrahydroxy stibane glucoside which is component of tuber fleece-flower root on nerve cells. Chin. J. Clin. Rehabil. 8: 118-120.
58. Zhang, L., Ye, C.F., Chu, Y.Q., Li, B., and Li, L. 2005. Effects of tetrahydroxystilbene glucoside on cholinergic system in dementia rats model induced by ibotenic acid. J. Chin. Pharm. 40: 749-752.
59. Zhang, L., Xing, Y., Ye, C.F., Ai, H.X., Wei, H.F., and Li, L. 2006. Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside. Behav. Brain Res. 173(2): 246-254. doi:10.1016/j.bbr.2006.06.034.
60. Zohar, O., Pick, C., Cavallaro, S., Chapman, J., Katzav, A., Milman, A., and Alkon, D.L. 2005. Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice. Neurobiol. Aging, 26(8): 1167-1175. doi:10.1016/j.neurobiolaging.2004.10.005.